Saluda Medical, Inc. (ASX:SLD)
Australia · Delayed Price · Currency is AUD 0.4320
-0.0230 (-5.05%)
Last updated: Sep 2, 2026, 12:34 PM AEST
Saluda Medical Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Cash & Equivalents | 118.62 | 54.5 | 71.79 | 166.74 |
Cash & Short-Term Investments | 118.62 | 54.5 | 71.79 | 166.74 |
Cash Growth | 117.64% | -24.09% | -56.94% | - |
Receivables | 20.5 | 12.64 | 11.13 | 5.94 |
Inventory | 32.47 | 43.33 | 28.98 | 16.81 |
Prepaid Expenses | 7.75 | 4.04 | 4.3 | 4.51 |
Other Current Assets | - | 2.8 | 0.7 | - |
Total Current Assets | 179.34 | 117.32 | 116.9 | 194 |
Property, Plant & Equipment | 6.84 | 8.33 | 9.08 | 10.55 |
Other Long-Term Assets | 2.21 | 3.02 | 1.36 | 6.62 |
Total Assets | 188.38 | 128.67 | 127.34 | 211.18 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Accounts Payable | 31.81 | 1.5 | 2.61 | 1 |
Accrued Expenses | - | 23.06 | 17.84 | 13.34 |
Short-Term Debt | - | 129.84 | - | - |
Current Portion of Leases | 1.22 | 1.12 | 0.82 | 0.59 |
Current Income Taxes Payable | - | 0.72 | 0.45 | 0.6 |
Current Unearned Revenue | - | 0.63 | - | - |
Total Current Liabilities | 33.03 | 156.86 | 21.72 | 15.52 |
Long-Term Debt | 96.34 | 71.39 | 67.71 | 62.84 |
Long-Term Leases | 2.19 | 2.77 | 3.25 | 3.96 |
Other Long-Term Liabilities | 2.27 | 3.19 | 4.6 | 5.36 |
Total Liabilities | 133.83 | 234.21 | 97.29 | 87.68 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Common Stock | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 781.13 | 86.54 | 72.42 | 68.66 |
Retained Earnings | -723.96 | -574.4 | -425.09 | -327.27 |
Comprehensive Income & Other | -2.61 | -3.35 | -3.67 | -4.29 |
Total Common Equity | 54.55 | -491.2 | -356.34 | -262.9 |
Shareholders' Equity | 54.55 | -105.54 | 30.06 | 123.5 |
Total Liabilities & Equity | 188.38 | 128.67 | 127.34 | 211.18 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Total Debt | 99.75 | 205.12 | 71.79 | 67.39 |
Net Cash (Debt) | 18.87 | -150.62 | 0.01 | 99.35 |
Net Cash Growth | - | - | -99.99% | - |
Net Cash Per Share | 0.12 | -46.32 | 0.00 | 30.62 |
Filing Date Shares Outstanding | 252.02 | 3.25 | 3.25 | 3.25 |
Total Common Shares Outstanding | 252.02 | 3.25 | 3.25 | 3.25 |
Working Capital | 146.3 | -39.55 | 95.18 | 178.48 |
Book Value Per Share | 0.22 | -150.93 | -109.70 | -81.01 |
Tangible Book Value | 54.55 | -491.2 | -356.34 | -262.9 |
Tangible Book Value Per Share | 0.22 | -150.93 | -109.70 | -81.01 |
Machinery | - | 7.8 | 6.86 | 6.41 |
Leasehold Improvements | - | 3.14 | 3.28 | 3.05 |